These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8646696)

  • 1. In vitro concurrent paclitaxel and radiation of four vulvar squamous cell carcinoma cell lines.
    Jaakkola M; Rantanen V; Grénman S; Kulmala J; Grénman R
    Cancer; 1996 May; 77(9):1940-6. PubMed ID: 8646696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation response of vulvar squamous cell carcinoma (UM-SCV-1A, UM-SCV-1B, UM-SCV-2, and A-431) cells in vitro.
    Pekkola-Heino K; Kulmala J; Grenman S; Carey TE; Grenman R
    Cancer Res; 1989 Sep; 49(17):4876-8. PubMed ID: 2758419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supra-additive effect with concurrent paclitaxel and cisplatin in vulvar squamous cell carcinoma in vitro.
    Raitanen M; Rantanen V; Kulmala J; Helenius H; Grénman R; Grénman S
    Int J Cancer; 2002 Jul; 100(2):238-43. PubMed ID: 12115575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vulvar squamous cell carcinoma cell lines are sensitive to paclitaxel in vitro.
    Jaakkola M; Rantanen V; Grénman S; Kulmala J; Grénman R
    Anticancer Res; 1997; 17(2A):939-43. PubMed ID: 9137431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel combined with fractionated radiation in vitro: a study with vulvar squamous cell carcinoma cell lines.
    Raitanen M; Rantanen V; Kulmala J; Pulkkinen J; Klemi P; Grénman S; Grénman R
    Int J Cancer; 2002 Feb; 97(6):853-7. PubMed ID: 11857367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck.
    Leonard CE; Chan DC; Chou TC; Kumar R; Bunn PA
    Cancer Res; 1996 Nov; 56(22):5198-204. PubMed ID: 8912857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel and radiotherapy: sequence-dependent efficacy--a preclinical model.
    Niero A; Emiliani E; Monti G; Pironi F; Turci L; Valenti AM; Marangolo M
    Clin Cancer Res; 1999 Aug; 5(8):2213-22. PubMed ID: 10473108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiosensitization of paclitaxel combined with radiation on nasopharygneal carcinoma cells (CNE-I) in vitro].
    Yuan ZY; Yang WZ; Jin J; Gao L; Liu XF; Xu GZ
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):649-52. PubMed ID: 18246791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant vinorelbine and radiation in head and neck squamous cell carcinoma in vitro.
    Erjala K; Pulkkinen J; Kulmala J; Grénman R
    Acta Oncol; 2004; 43(2):169-74. PubMed ID: 15163165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel in simultaneous radiochemotherapy of head and neck cancer: preclinical and clinical results.
    Hoffmann W; Rodemann HP; Belka C; Budach W; Schmidberger H; Bochtler H; Heinrich V; Bamberg M
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-72-S2-77. PubMed ID: 9045342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel and irradiation induce apoptosis in squamous cell carcinoma cell lines in an additive way.
    Pulkkinen JO; Pekkola-Heino K; Grénman R
    Anticancer Res; 1996; 16(5A):2923-9. PubMed ID: 8917408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose irradiation and short-exposure suboptimal-dose paclitaxel adversely modulate metastatic potential of squamous carcinoma cells.
    Lövey J; Fazekas K; Ladányi A; Németh G; Tímár J
    Strahlenther Onkol; 2003 Dec; 179(12):812-8. PubMed ID: 14652669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taxol and radiation.
    Geard CR; Jones JM; Schiff PB
    J Natl Cancer Inst Monogr; 1993; (15):89-94. PubMed ID: 7912535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel-induced modification of the effects of radiation and alterations in the cell cycle in normal and tumor mammalian cells.
    Gorodetsky R; Levdansky L; Ringel I; Vexler A
    Radiat Res; 1998 Sep; 150(3):283-91. PubMed ID: 9728657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive radiation therapy concurrent with up to 7-week continuous-infusion paclitaxel for locally advanced solid tumors: phase I studies.
    Rosenthal DI; Okani O; Truelson JM; Fathallah-Shaykh H; Vuitch FM; Gazdar AF; Griener J; Landay M; Mendelsohn D; Tourville J; Hamilton L; Orr KY; McWhorter J; Carbone DP
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-81-S2-84. PubMed ID: 9045344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel and cisplatin sensitivity of ovarian carcinoma cell lines tested with the 96-well plate clonogenic assay.
    Engblom P; Rantanen V; Kulmala J; Grènman S
    Anticancer Res; 1996; 16(4A):1743-7. PubMed ID: 8712694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel: a radiation sensitizer of human cervical cancer cells.
    Rodriguez M; Sevin BU; Perras J; Nguyen HN; Pham C; Steren AJ; Koechli OR; Averette HE
    Gynecol Oncol; 1995 May; 57(2):165-9. PubMed ID: 7729728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose fractionated radiation potentiates the effects of Paclitaxel in wild-type and mutant p53 head and neck tumor cell lines.
    Dey S; Spring PM; Arnold S; Valentino J; Chendil D; Regine WF; Mohiuddin M; Ahmed MM
    Clin Cancer Res; 2003 Apr; 9(4):1557-65. PubMed ID: 12684432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schedule-dependent interaction of paclitaxel (Taxol) and irradiation in vitro.
    Plasswilm L; Cordes N; Sauer R
    Radiat Oncol Investig; 1998; 6(1):10-7. PubMed ID: 9503485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel is only a weak radiosensitizer of human cervical carcinoma cell lines.
    Erlich E; McCall AR; Potkul RK; Walter S; Vaughan A
    Gynecol Oncol; 1996 Feb; 60(2):251-4. PubMed ID: 8631547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.